USPTO serial 79296108
SEEGENE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 2021
- Examiner
- SMITH, TARYN E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SEEGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Corey K. Cho
Corey K. Cho Saliwanchik Lloyd & Eisenschenk, P.A.3107 SW Williston RdGainesville, FL 32608UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for industrial purposes; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical purposes; electrophoresis gels, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; enzymes for scientific and research purposes; industrial chemicals; photometric paper; reagent paper, other than for medical or veterinary purposes; chemical test paper; stem cells, other than for medical or veterinary purposes; reagents for scientific and research use, namely, detecting and analyzing genetic material; nucleic acid sequences for amplifying and detecting genetic material for other than medical and veterinary purposes; reagents for scientific and research use, namely, amplifying and detecting genetic material; diagnostic reagents for in vitro use in biochemistry, clinical chemistry or microbiology; reagents for analyzing nucleic acid for industrial, scientific or laboratory purposes; reagents for use in genetic research; polymerase for nucleic acid amplifications for scientific or laboratory purposes; nucleic acid for scientific or laboratory purposes; diagnostic preparations for scientific or laboratory use; reagents for scientific or laboratory use, namely, nucleic acid and chemicals used for their synthesis; reagents for scientific, research or laboratory use; in vitro diagnostic reagents for scientific, research or laboratory use | ACTIVE | — |
| 009 | Incubators for bacteria culture; food analysis apparatus; chemistry apparatus and instruments, namely, test tubes and pipette tips; optical apparatus and instruments except for glasses and photographic apparatus, namely, optical sensors, optical inspection apparatus, optical detectors and optical lenses; Apparatus for testing protein and nucleic acid not for medical purposes; diagnostic apparatus for the detection of pathogens, not for medical purposes; immunofluorescence measuring apparatus not for medical purposes; absorption measuring apparatus not for medical purposes; DNA chips; bio-chips for research and scientific purposes; apparatus for analyzing protein and nucleic acid for laboratory use; laboratory apparatus and instruments for preparing nucleic acid samples; laboratory apparatus for extracting and purifying nucleic acid; nucleic acid amplification apparatus for laboratory use; real-time nucleic acid amplification apparatus for laboratory use | ACTIVE | — |
| 010 | protein analysis apparatus for medical diagnostic purposes; medical analysis apparatus for use in gene analysis and genetic disease diagnosis; immuneofluorescence analysis apparatus for medical purposes; medical absorption analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins; clinical-chemical auto analysis apparatus for medical use; blood analysis apparatus for medical use; body fluid and tissues sample analysis apparatus for medical purposes; nucleic acid analysis apparatus for medical purposes; diagnostic apparatus for medical use, used for the diagnosis of infection of microorganisms; bacteria and virus testing apparatus for medical diagnostic purposes; blood cell testing apparatus for medical diagnostic purposes; immune testing apparatus for medical purposes; gene testing apparatus for medical purposes; clinical diagnosis apparatus for genetic diseases; clinical diagnosis apparatus for infectious diseases; medical apparatus and instruments for taking blood, cell, saliva and sputum sample specimens; medical apparatus and instruments for extracting and purifying nucleic acid; medical apparatus and instruments for extracting and purifying protein; medical apparatus and instruments for nucleic acid amplification; real-time gene amplification equipment for medical use; diagnostic biochips for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SEEGENE, INC.
- Other trademarks owned by SEEGENE, INC.
- Other trademarks owned by SEEGENE, INC.
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named SEEGENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 13, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 23, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 23, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 29, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 29, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 29, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 29, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 16, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 19, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |